Identification of potential key genes and immune infiltration in Multiple sclerosis
Multiple Sclerosis and Related Disorders, ISSN: 2211-0348, Vol: 60, Page: 103748
2022
- 3Citations
- 13Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- CrossRef1
- Captures13
- Readers13
- 13
Article Description
Multiple sclerosis (MS) is an extremely serious autoimmune disease of the nervous system. Extensive evidence indicated that immune system activation plays a crucial role in the development of MS. However, the exact mechanism of MS is still not well understood. Our objective was to identify potential key genes of Multiple sclerosis (MS) via bioinformatic analysis and apply CIBERSORT algorithms to calculate the proportion of infiltrating immune cells. The differentially expressed genes (DEGs) were analyzed from two public datasets, which included 99 MS, 45 controls and 133 MS, 79 controls. Then the common DEGs were obtained ( p < 0.05). LASSO regression analysis was performed on common DEGs of GSE17048. The receiver operating characteristic (ROC) curves were created. The key genes were screened based on area under the receiver operating characteristic curve (AUC). CIBERSORT algorithms were used to explore the immune infiltration in MS. 516 common DEGs were screened from two public datasets. And then 54 signature genes were obtained by constructing LASSO model. MS4A6A, CACNA1I, C9orf46, EIF4EBP2, SERTAD2, TGFBR2 and RAB34 with the largest AUC values were selected as the key genes. Neutrophils, Monocytes, resting memory CD4 + T cells, CD8 + T cells and resting NK cells accounted for a large proportion of infiltrating immune cells in MS. MS4A6A, CACNA1I, C9orf46, EIF4EBP2, SERTAD2, TGFBR2 and RAB34 may be closely related pathogenesis of MS, and may represent new candidate biomarkers. In addition, immune cell infiltration may also play an important role in the progression of MS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211034822002632; http://dx.doi.org/10.1016/j.msard.2022.103748; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85126873732&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35339006; https://linkinghub.elsevier.com/retrieve/pii/S2211034822002632; https://dx.doi.org/10.1016/j.msard.2022.103748
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know